2024-05-08 07:16:00 ET
Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-trillion-dollar behemoth where investment opportunities abound.
Sifting through the industry revealed three blue chip stocks with stellar records of execution, future growth opportunities, and an enticing dividend. They offer both passive income and reinvestment potential that could boost overall returns.
Here is why Johnson & Johnson (NYSE: JNJ) , Abbott Labs (NYSE: ABT) , and Pfizer (NYSE: PFE) should all be on your radar as a long-term investor. You can own a share of each for less than $1,000 all-in.
For further details see:
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever